β-Cyclodextrin Encapsulated Platinum(II)-Based Nanoparticles: Photodynamic Therapy and Inhibition of the NF-κB Signaling Pathway in Glioblastoma
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.5c00103 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Sakira Tabassum Borah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, Indian Institute of Science Education and Research, Kolkata, India 741246. Hauptthemen laut MEDLINE: beta-Cyclodextrins, Glioblastoma, Platinum, Photochemotherapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, Indian Institute of Science Education and Research, Kolkata, India 741246.
- Department of Biological Sciences, Indian Institute of Science Education and Research, Kolkata, India 741246.
ORCID-Profile: Bishnu Das, Jayasri Das Sarma, Parna Gupta
Zitieren
APA
Borah, S. T., Mondal, A., Das, B., Saha, S., Das Sarma, J., & Gupta, P. (2025). β-Cyclodextrin Encapsulated Platinum(II)-Based Nanoparticles: Photodynamic Therapy and Inhibition of the NF-κB Signaling Pathway in Glioblastoma. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c00103
Vancouver
Borah ST, Mondal A, Das B, Saha S, Das Sarma J, Gupta P. β-Cyclodextrin Encapsulated Platinum(II)-Based Nanoparticles: Photodynamic Therapy and Inhibition of the NF-κB Signaling Pathway in Glioblastoma. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c00103
BibTeX
@article{Borah2025,
author = {Borah, Sakira Tabassum and Mondal, Anushka and Das, Bishnu and Saha, Sanchari and Das Sarma, Jayasri and Gupta, Parna},
title = {β-Cyclodextrin Encapsulated Platinum(II)-Based Nanoparticles: Photodynamic Therapy and Inhibition of the NF-κB Signaling Pathway in Glioblastoma},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.5c00103}
}
EUVIMED